A Grim link: the association between subclinical atherosclerosis and epigenetic age.
A Grim link: the association between subclinical atherosclerosis and epigenetic age.
复制标题
严峻的联系:亚临床动脉粥样硬化与表观遗传年龄之间的关联。
DOI:
10.1093/eurheartj/ehad326
复制
发表时间:
2023
影响因子:
39.3
通讯作者:
Lee,RichardT
中科院分区:
文献类型:
--
作者:
Velayutham,Nivedhitha;Lee,RichardT
Atherosclerosis and many other cardiovascular diseases are very age dependent, with chronological age a major risk factor for cardiac disease. 1, 2 Atherosclerotic plaques can accumulate in otherwise healthy individuals with age, remaining clinically silent for years as subclinical atherosclerosis (SA). 3 The highest prevalence of SA is in middle-aged individuals. Understanding the interplay of ageing and pathogenesis of SA and uncovering early biomarkers of SA are important, as clinical manifestation of initial symptoms can be lethal. Biological ageing seems to progress at different rates amongst individuals with the same chronological age, with significant variation in physiological and functional hallmarks of ageing. 4 Epigenetic parameters such as DNA methylation patterns vary significantly between individuals of the same chronological age and are demonstrably linked to human ageing. 4, 5 Rigorous study of the dynamic landscape of epigenetic changes has established ‘epigenetic clocks’, which can provide biological vs. chronological age of an individual, and thus a prediction of health and life span. Further, epigenetic age acceleration (EAA) defines the difference between epigenetic age and chronological age, and is strongly associated with many variables of health, disease, and ageing in humans. 5 The emerging association between cardiovascular diseases and EAA highlights the potential usefulness of EAA as a biomarker of cardiovascular disease. 6